-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Sarepta Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2015 to 2023.
- Sarepta Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $4.92M, a 5.95% decline year-over-year.
- Sarepta Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $19.2M, a 18.4% decline year-over-year.
- Sarepta Therapeutics, Inc. annual Interest Expense for 2023 was $22M, a 58.7% decline from 2022.
- Sarepta Therapeutics, Inc. annual Interest Expense for 2022 was $53.2M, a 16.2% decline from 2021.
- Sarepta Therapeutics, Inc. annual Interest Expense for 2021 was $63.5M, a 5.97% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)